Mike Denvir is a Partner of The Jordan Company. He is also a member of the firm’s Partnership Board and Executive Committee.
Mike joined TJC in 1998. He currently serves on the board of directors of ARCH, CFS Brands, Dimora and Worldwide Clinical Trials.
Mike holds a BA degree in Economics from the University of Notre Dame.